These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18172580)

  • 1. Solid lipid nanoparticles as delivery systems for bromocriptine.
    Esposito E; Fantin M; Marti M; Drechsler M; Paccamiccio L; Mariani P; Sivieri E; Lain F; Menegatti E; Morari M; Cortesi R
    Pharm Res; 2008 Jul; 25(7):1521-30. PubMed ID: 18172580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study.
    Esposito E; Mariani P; Ravani L; Contado C; Volta M; Bido S; Drechsler M; Mazzoni S; Menegatti E; Morari M; Cortesi R
    Eur J Pharm Biopharm; 2012 Feb; 80(2):306-14. PubMed ID: 22061262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanocarriers containing a levodopa prodrug with potential antiparkinsonian activity.
    Ravani L; Sarpietro MG; Esposito E; Di Stefano A; Sozio P; Calcagno M; Drechsler M; Contado C; Longo F; Giuffrida MC; Castelli F; Morari M; Cortesi R
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():294-300. PubMed ID: 25579926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone lipid nanoparticles: Scaling up and in vivo human study.
    Esposito E; Sguizzato M; Drechsler M; Mariani P; Carducci F; Nastruzzi C; Cortesi R
    Eur J Pharm Biopharm; 2017 Oct; 119():437-446. PubMed ID: 28760448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
    Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
    J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
    Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
    Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term restorative effects of bromocriptine on operant responding in the 6-hydroxydopamine-lesioned rat.
    Murphy EM; Lelos MJ; O'Neill MJ; Lane EL; Dunnett SB
    Neuroreport; 2013 Dec; 24(18):1019-24. PubMed ID: 24145771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles as delivery systems for Gambogenic acid.
    Huang X; Chen YJ; Peng DY; Li QL; Wang XS; Wang DL; Chen WD
    Colloids Surf B Biointerfaces; 2013 Feb; 102():391-7. PubMed ID: 23010123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and Characterization of Nanoparticle Based Hyaluronate Gel Containing Retinyl Palmitate for Wound Healing.
    Esposito E; Pecorelli A; Sguizzato M; Drechsler M; Mariani P; Carducci F; Cervellati F; Nastruzzi C; Cortesi R; Valacchi G
    Curr Drug Deliv; 2018; 15(8):1172-1182. PubMed ID: 29779480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
    Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
    Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
    Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
    Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
    Rosenblatt KM; Bunjes H
    Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.